GHRP-6 is a popular stimulator of GH, suitable during bulking phases. It increases IGF-1 and appetite, helps with better intake of calories and nutrients. It is combined with CJC-1295 or GHRH peptides.
- 0%
- 0%
- 0%
- 0%
- 0%
Report this review.
What is the peptide GHRP-6?
This peptide “encourages” the body briefly to release more of its endogenous growth hormone, which can alter how the organism uses energy and repairs tissues, without the product itself being a hormone.
As a synthetic growth hormone secretagogue, the molecule is an agonist of the ghrelin receptor (GHSR1a) and activates GPCR-linked signaling cascades (incl. PLC/IP3–Ca2+), which stimulate pulsatile release of GH from the pituitary (reference context: Wikipedia: Growth hormone-releasing peptide-6; review sources for ghrelin/GHSR biology: PubMed).
Mechanism of action (MOA)
The effect is viewed as receptor-mediated secretagogue stimulation: binding to GHSR1a → intracellular Ca2+ signaling → exocytosis of GH. In experimental design this is assessed by serial blood samples (GH/IGF-1) and pulsatility models, with control of nutritional status and circadian factors. Important: the molecule is not an approved medicinal substance and interpretation of results should be within the framework of research protocols.
Literature data (limited for publicly available numerical parameters)
| study name | population or experimental model | number of subjects or samples | duration | key observed outcomes |
|---|---|---|---|---|
| Published data for the GHRP class of secretagogues (review) | human and preclinical models (summary) | not applicable (review) | not applicable | descriptions of GH response are available, but numerical parameters for GHRP-6 are heterogeneous and not standardized in freely accessible texts |
Due to variability in design and dosing in the available publications, no quantitative claims are made here without traceable numerical data; for primary tables and curves it is recommended to search in PubMed and compare with regulatory positions for related axes (e.g., general principles for clinical evaluation of GH/IGF-1: EMA).
Context of scientific use and laboratory setting
Typical applications: cell systems expressing GHSR1a, ex vivo tissues, and in vivo models for endocrine dynamics. Pharmacokinetic parameters are highly dependent on route of administration and matrix; for reliable experiments timepoints for early peaks and rapid decline are planned, plus analytical validation (LC–MS/ELISA, where applicable).
Purity
GHRP-6 from MyPeptid provides conditions for reproducible testing, as it has a declared purity >99% (suitable for QC, method development and biological panels).
Formula: C46H56N12O6
Sale for educational and research purposes only (research-only); not intended for human use or clinical application.
Similar
